No black box warning on record for Glipizide And Metformin Hcl

As of the latest FDA labeling reviewed, Glipizide And Metformin Hcl (GLIPIZIDE AND METFORMIN HCL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Glipizide And Metformin Hcl medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS SPECIAL WARNING ON INCREASED RISK OF CARDIOVASCULAR MORTALITY The administration of oral hypoglycemic drugs has been reported to be associated with increased cardiovascular mortality as compared to treatment with diet alone or diet plus insulin. This warning is based on the study conducted by the University Group Diabetes Program (UGDP), a long-term prospective clinical trial designed to

No black box warning on record for Glipizide And Metformin Hcl

Other warnings & precautions

WARNINGS SPECIAL WARNING ON INCREASED RISK OF CARDIOVASCULAR MORTALITY The administration of oral hypoglycemic drugs has been reported to be associated with increased cardiovascular mortality as compared to treatment with diet alone or diet plus insulin. This warning is based on the study conducted by the University Group Diabetes Program (UGDP), a long-term prospective clinical trial designed to

Glipizide And Metformin Hcl Black Box Warning

No black box warning on record for Glipizide And Metformin Hcl

Other warnings & precautions

Glipizide And Metformin Hcl Black Box Warning

No black box warning on record for Glipizide And Metformin Hcl

Other warnings & precautions